Clinical trials of the first drugs designed with the help of artificial intelligence could commence this year, Google ...
The director of the corporation’s scientific laboratory points to genomics, nuclear fusion and the development of new ...
Called AlphaFold 3, the new AI software represents a major update and expansion of capabilities beyond Google DeepMind’s previous AlphaFold 2 system. Researchers from the companies published a ...
Among the most important aspects of this story is AlphaFold, the artificial intelligence and foundation model platform developed by Google DeepMind and Isomorphic Labs, both Alphabet companies.
Google parent Alphabet has drawn on its DeepMind artificial intelligence ... and earlier this year a new version – AlphaFold2 – was made freely available to researchers around the world.
Google DeepMind and EMBL’s freely available AlphaFold2 has had a big impact on research into the role of proteins in disease since its launch in 2021 and is already being used to develop new ...
He tells Sumiko Tan how he spent long summers in Singapore as a child with his Singapore-born mum. Read more at straitstimes.com.